PM360

OCTOBER 5, 2023

In total, PM360 , a leading life sciences marketing industry trade publication, recognized 73 winners across eight overall categories: Companies of the Year, CEOs of the Year, Products of the Year, Marketer of the Year, Marketing Team of the Year, Lifetime Achievement, Brand Champions, and Initiatives. Cardiology: Bradley A.

Education 52

Education Marketing Media Biopharma 52

pharmaphorum

JULY 27, 2022

Demerging Haleon has allowed GSK to focus on higher-margin prescription medicines and vaccines, as well as provide cash for investment in its biopharma pipeline. GSK has already made moves in this direction this year with deals to buy cancer specialist Sierra Oncology for $1.9 billion and vaccine firm Affinivax for up to $3.3

Sales 52

Sales Biopharma Prescription Medicine 52

PM360

AUGUST 24, 2023

PM360 , a leading life sciences marketing industry trade publication, established the Trailblazer Awards in 2009 to recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. Braun Medical, Inc.

Marketing 52

Marketing Education Media Healthcare 52

The Marketing Advantage

MAY 8, 2023

May 9, 2023 Since the Orphan Drug Act was passed in 1983, the number of products being researched and approved for rare and orphan diseases has increased dramatically, offering hope and life-saving treatments for the millions of patients affected by these often under-served conditions.

Sales 52

Sales Physicians Consulting Education 52

Clarivate

APRIL 19, 2024

Liver cancer and focal liver lesions Liver cancer ranks as the third-leading cause of cancer-related deaths worldwide. [5] 7] FLLs are often found incidentally during imaging for other purposes, such as the assessment of abdominal pain or during surveillance for liver metastases in patients with non-liver cancer. [8]

Medical 59

Medical Patients Specialization Healthcare 59

Pharma Marketing Network

JANUARY 12, 2023

Advancing medicine, advancing patient care, and advancing equity in our global workforce are shared values of this year’s honorees driving transformational change and impact,” said Wendy White, interim CEO and 2022 STAR, HBA. These experiences have empowered Christi to become a leading industry voice advocating fiercely for patients.

Healthcare 52

Healthcare Healthcare Networking Manufacturing 52

Clarivate

DECEMBER 6, 2022

These health systems combine multiple sites and services, and sometimes a health maintenance organization, to provide end-to-end care to patients locally or regionally. states and the United Kingdom and sees more than 35 million patient encounters per year. Bill Melville, Lead Healthcare Research Analyst.

Networking 52

Networking Healthcare Healthcare Competition 52

Pharmaceutical Technology

JANUARY 20, 2023

The demand for mAbs is increasing as they offer patients targeted treatments for a wide range of serious health conditions and diseases. Nevertheless, the potential for mAb therapies in treating medical conditions that have limited options means that biopharma companies are investing considerable resources in development.

Biopharma 52

Biopharma Manufacturing Specialization Engineering 52

PM360

JUNE 30, 2022

Now, the two companies will unite their full suite of advisory, medical, marketing, communications, and patient and stakeholder engagement services to create a new organization called Inizio. The unit will specialize in medical communications, medical affairs, real-world evidence, and outcomes research.

Specialization 97

Specialization Healthcare Healthcare Consulting 97

PM360

JUNE 16, 2023

Francis Pang, Global Head of Market Access at Orchard Therapeutics noted that “payers globally want a menu of innovative pricing mechanisms: guaranteed outcomes, pay for performance, long duration of risk sharing, tiered pricing, and caps on the number of patients and doses.” rebates, paybacks, or earned payments) (Figure 1). In the U.S.,

Marketing 98

Marketing Management Insurance Specialization 98

pharmaphorum

JANUARY 11, 2023

Last year, digital health ventures registered a total of 575 regulatory filings around the world, with the medical diagnostics cluster – diagnostic tools, medical imaging, and omics-related analyses – leading the charge with 12% of the total. Roche tops biopharma partnering podium.

Biopharma 73

Biopharma Specialization Physicians Healthcare 73

Pharmaceutical Technology

MAY 24, 2023

The ability to modify or introduce genetic material in human cells in such a precise and patient-centered manner clearly constitutes a breakthrough in personalized medicine. Allogeneic therapies begin with healthy donor samples to develop the eventual therapeutic product which can be administered to multiple patients.

Manufacturing 98

Manufacturing Transportation Specialization Patients 98

Pharmaceutical Technology

AUGUST 26, 2008

“The inherent advantages of biopharma are that it allows you to pursue therapies against targets that are not small molecule therapies, for example by targeting protein-protein interactions and targeting GPCRs (G-protein coupled receptors),” he says. “Biotechnology has exploded across the industry. .

Manufacturing 52

Manufacturing Pharmaceutical Biopharma Medicine 52

European Pharmaceutical Review

DECEMBER 21, 2022

Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure. During his time at Genentech Stefan has advanced several small molecules and new modalities (antibody‑drug conjugates, oligonucleotides and peptides) into the clinic as lead chemist and technical development leader.

Manufacturing 74

Manufacturing Pharmaceutical Healthcare Healthcare 74

Medgadget

MARCH 2, 2023

This leads to substantial damage to healthy tissues and too often results in poor outcomes. Special software that takes DICOM images from CT scanners and creates a treatment plan, defines the distribution of the Alpha DaRT sources within the tumor. The rest of the patients had partial responses.

Manufacturing 83

Manufacturing Leads Patients Medicine 83

Pharmaceutical Technology

APRIL 24, 2023

The rise of biologics In the lead-up to the 2020 boom, Swiss drugmaker Roche spent some $11 billion on biotechnology research and development in 2018. Because biologics work with live cells, manufacturing them is difficult, and highly specialized facilities and infrastructure are needed.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52

Pharmaceutical Technology

MARCH 20, 2023

These high rates of diseases in largely untapped patient pools, present invaluable opportunities to trial new drugs that can help people living with chronic conditions and battling serious illnesses. of patients who take part in clinical trials are from a Caucasian background, which rises further to 84.2% being African American, 3.4%

Distribution 52

Distribution Management Patients Transportation 52

Pharmaceutical Technology

JANUARY 25, 2023

Although expert opinions differ on the future of special purpose acquisition companies (SPACs), some companies are continuing to explore their use. In December 2022, AEON Biopharma, a biopharmaceutical company, announced its plans to go public through a merger with the SPAC Priveterra Acquisition Corp.

Marketing 69

Marketing Biopharma Pharma Competition 69